Point72 Asia (Singapore) Pte. Ltd. Ocular Therapeutix, Inc Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $646 Billion
- Q3 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 1,216 shares of OCUL stock, worth $13,825. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,216
Previous 11,868
89.75%
Holding current value
$13,825
Previous $110 Million
87.09%
% of portfolio
0.0%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding OCUL
# of Institutions
237Shares Held
158MCall Options Held
1.24MPut Options Held
423K-
Vr Adviser, LLC New York, NY13.2MShares$150 Million23.37% of portfolio
-
Summer Road LLC West Palm Beach, FL12.6MShares$143 Million98.91% of portfolio
-
Deep Track Capital, LP Greenwich, CT11.9MShares$136 Million4.4% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$131 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.3MShares$117 Million1.64% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $875M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...